Lola Burke1, Lesley-Ann Miller, Ayman Saad, Jame Abraham. 1. Hematology and Oncology, Mary Babb Randolph Cancer Center, and the School of Medicine, West Virginia University, Morgantown, WV; Division of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston, TX; Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, WI.
Abstract
PURPOSE: Smoking is a well-recognized risk factor for several cancers including cancers of the lung, bladder, and head and neck. Studies have shown that smoking can adversely affect the outcomes of different modalities of cancer treatment. This study examines smoking behaviors among cancer survivors to collect information necessary to create successful smoking cessation interventions. METHODS: For this observational clinical study, questionnaires were sent to 1,000 randomly selected patients diagnosed with cancer between 2003 and 2007 in one cancer center. Data were statistically analyzed to determine the likelihood of a patient quitting smoking after being diagnosed with cancer. RESULTS: We received 187 responses from the 1,000 surveys sent (18.7%). Of these, 166 were usable for analysis. The mean age of respondents was 64 (± 13) years. Men were more likely than women to be past smokers (55% of men and 32% of women respectively, P = .003). Fifty-two percent of respondents reported having a history of smoking. However, only 20% of patients reported having been active smokers at the time they were diagnosed with cancer. Furthermore, only 44% of these reported having quit smoking after their diagnosis with cancer. Only 62% of all respondents reported that they had been informed of the dangers of smoking by their health care provider during cancer treatment. CONCLUSION: In our study sample, less than one half (44%) of smoking cancer patients quit smoking after their cancer diagnosis, and only 62% of smoking cancer patients received smoking cessation counseling from their physicians. Intervention programs are needed to help cancer survivors to quit smoking. Prospective clinical trials may help identify the ideal intervention for smoking cessation.
PURPOSE: Smoking is a well-recognized risk factor for several cancers including cancers of the lung, bladder, and head and neck. Studies have shown that smoking can adversely affect the outcomes of different modalities of cancer treatment. This study examines smoking behaviors among cancer survivors to collect information necessary to create successful smoking cessation interventions. METHODS: For this observational clinical study, questionnaires were sent to 1,000 randomly selected patients diagnosed with cancer between 2003 and 2007 in one cancer center. Data were statistically analyzed to determine the likelihood of a patient quitting smoking after being diagnosed with cancer. RESULTS: We received 187 responses from the 1,000 surveys sent (18.7%). Of these, 166 were usable for analysis. The mean age of respondents was 64 (± 13) years. Men were more likely than women to be past smokers (55% of men and 32% of women respectively, P = .003). Fifty-two percent of respondents reported having a history of smoking. However, only 20% of patients reported having been active smokers at the time they were diagnosed with cancer. Furthermore, only 44% of these reported having quit smoking after their diagnosis with cancer. Only 62% of all respondents reported that they had been informed of the dangers of smoking by their health care provider during cancer treatment. CONCLUSION: In our study sample, less than one half (44%) of smoking cancerpatients quit smoking after their cancer diagnosis, and only 62% of smoking cancerpatients received smoking cessation counseling from their physicians. Intervention programs are needed to help cancer survivors to quit smoking. Prospective clinical trials may help identify the ideal intervention for smoking cessation.
Authors: Robert A Schnoll; Calvin James; Michael Malstrom; Randi L Rothman; Hao Wang; James Babb; Suzanne M Miller; John A Ridge; Benjamin Movsas; Corey Langer; Michael Unger; Melvyn Goldberg Journal: Ann Behav Med Date: 2003
Authors: E R Gritz; C R Carr; D A Rapkin; C Chang; J Beumer; P H Ward Journal: Cancer Epidemiol Biomarkers Prev Date: 1991 Nov-Dec Impact factor: 4.254
Authors: G L Day; W J Blot; R E Shore; J K McLaughlin; D F Austin; R S Greenberg; J M Liff; S Preston-Martin; S Sarkar; J B Schoenberg Journal: J Natl Cancer Inst Date: 1994-01-19 Impact factor: 13.506
Authors: A Johnston-Early; M H Cohen; J D Minna; L M Paxton; B E Fossieck; D C Ihde; P A Bunn; M J Matthews; R Makuch Journal: JAMA Date: 1980-11-14 Impact factor: 56.272
Authors: J S Ostroff; P B Jacobsen; A B Moadel; R H Spiro; J P Shah; E W Strong; D H Kraus; S P Schantz Journal: Cancer Date: 1995-01-15 Impact factor: 6.860
Authors: Elizabeth L Kacel; Janae L Kirsch; Timothy S Sannes; Seema Patidar; Rachel Postupack; Sally Jensen; Shan Wong; Stephanie Garey; Stacy Dodd; Chantel M Ulfig; Christina S McCrae; Michael E Robinson; Jacqueline Castagno; Gregory S Schultz; Deidre B Pereira Journal: Health Psychol Date: 2019-08-01 Impact factor: 4.267
Authors: Jenine K Harris; Julianne Cyr; Bobbi J Carothers; Nancy B Mueller; Victoria V Anwuri; Aimee I James Journal: Am J Public Health Date: 2011-05-12 Impact factor: 9.308
Authors: Godfred O Antwi; David K Lohrmann; Wasantha Jayawardene; Angela Chow; Cecilia S Obeng; Aaron M Sayegh Journal: J Cancer Surviv Date: 2019-04-06 Impact factor: 4.442
Authors: H Naik; X Qiu; M C Brown; L Eng; D Pringle; M Mahler; H Hon; K Tiessen; H Thai; V Ho; C Gonos; R Charow; V Pat; M Irwin; L Herzog; A Ho; W Xu; J M Jones; D Howell; G Liu Journal: Curr Oncol Date: 2016-12-21 Impact factor: 3.677
Authors: Elyse R Park; Jamie S Ostroff; Giselle K Perez; Kelly A Hyland; Nancy A Rigotti; Sarah Borderud; Susan Regan; Alona Muzikansky; Emily R Friedman; Douglas E Levy; Susan Holland; Justin Eusebio; Lisa Peterson; Julia Rabin; Jacob Miller-Sobel; Irina Gonzalez; Laura Malloy; Maureen O'Brien; Suhana de León-Sanchez; C Will Whitlock Journal: Contemp Clin Trials Date: 2016-07-19 Impact factor: 2.226